G. Aßmann

4.2k total citations
98 papers, 1.8k citations indexed

About

G. Aßmann is a scholar working on Rheumatology, Molecular Biology and Surgery. According to data from OpenAlex, G. Aßmann has authored 98 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 20 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in G. Aßmann's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (10 papers) and Cancer, Lipids, and Metabolism (9 papers). G. Aßmann is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (10 papers) and Cancer, Lipids, and Metabolism (9 papers). G. Aßmann collaborates with scholars based in Germany, United States and United Kingdom. G. Aßmann's co-authors include H. Schulte, B. Dufaux, W Hollmann, Michael Pfreundschuh, Henrike Lenzen, R Buchwalsky, Pierre Simon, G. Schmitz, H J Menzel and Jan Voswinkel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

G. Aßmann

93 papers receiving 1.7k citations

Peers

Countries citing papers authored by G. Aßmann

Since Specialization

Citations

This map shows the geographic impact of G. Aßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Aßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Aßmann more than expected).

Fields of papers citing papers by G. Aßmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Aßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Aßmann. The network helps show where G. Aßmann may publish in the future.

Co-authorship network of co-authors of G. Aßmann

This figure shows the co-authorship network connecting the top 25 collaborators of G. Aßmann. A scholar is included among the top collaborators of G. Aßmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Aßmann. G. Aßmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres 2024 ·Clinical and Experimental Rheumatology ·G. Aßmann, (unknown), Sebastian Klapa, (unknown), Kerstin Amann, (unknown), J. Radermacher, Peter Lamprecht	0
2	Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis 2024 ·Immunology Letters ·(unknown), Natalie Fadle, Evi Regitz, Igor Age Kos, (unknown), (unknown), Klaus‐Dieter Preuss, (unknown), (unknown), Vincent Zimmer, Philipp Klemm, G. Aßmann, (unknown), Joerg Thomas Bittenbring, Moritz Bewarder, Thomas Vogt, Claudia Pföhler, (unknown), Christoph Kessel, Lorenz Thurner	2
3	VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma 2020 ·European Journal Of Haematology ·Dominic Kaddu‐Mulindwa, Maciej Rosołowski, Marita Ziepert, Evi Regitz, G. Aßmann, Moritz Bewarder, Gerhard Held, Michael Pfreundschuh, Joerg Thomas Bittenbring	4
4	Erfahrungen und Ergebnisse aus Rheuma-VOR 2019 ·Zeitschrift für Rheumatologie ·Andreas Schwarting, (unknown), G. Aßmann, Torsten Witte, Kirsten Hoeper, Reinhold Schmidt	7
5	VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs 2018 ·Arthritis Research & Therapy ·David Schub, G. Aßmann, Urban Sester, Martina Sester, Tina Schmidt	10
6	Lymphome bei rheumatischen Erkrankungen 2017 ·Zeitschrift für Rheumatologie ·Andrea Rubbert‐Roth, Joerg Thomas Bittenbring, G. Aßmann	1
7	Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment 2014 ·SpringerPlus ·G. Aßmann, (unknown), Michael Pfreundschuh, Rainer M. Bohle, Vincent Zimmer	9
8	HPV-assoziierte oropharyngeale Karzinome 2014 ·Der Pathologe ·Martin Mollenhauer, G. Aßmann, Pamela Zengel, Orlando Guntinas‐Lichius, Stephan Ihrler	4
9	Genetics of toll like receptor 9 in ANCA associated vasculitides 2013 ·Annals of the Rheumatic Diseases ·(unknown), Julia U. Holle, Frank Moosig, Sebastian Mueller, Benjamin Wilde, J. W. Cohen Tervaert, Lorraine Harper, G. Aßmann, Wolfgang L. Gross, Jörg T. Epplen, Stefan Wieczorek	33
10	Genetic polymorphism of the OPG gene associated with breast cancer 2013 ·BMC Cancer ·(unknown), Ingolf Juhasz-Böess, (unknown), Stefan Graeber, Rainer M. Bohle, Michael Pfreundschuh, Erich Solomayer, G. Aßmann	20
11	The SAPHO syndrome – Are microbes involved? 2011 ·Best Practice & Research Clinical Rheumatology ·G. Aßmann, Pierre Simon	58
12	Genetic Variations in Genes Encoding RANK, RANKL, and OPG in Rheumatoid Arthritis: A Case-Control Study 2010 ·The Journal of Rheumatology ·G. Aßmann, Jochem Koenig, Michael Pfreundschuh, Jörg T. Epplen, Joern Kekow, Klaus Roemer, Stefan Wieczorek	34
13	Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener’s granulomatosis and Churg–Strauss syndrome 2010 ·Lara D. Veeken ·Stefan Wieczorek, Julia U. Holle, Jan Phillip Bremer, (unknown), Frank Moosig, Harald Fricke, G. Aßmann, Lorraine Harper, Larissa Arning, Wolfgang L. Gross, Jörg T. Epplen	18
14	Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: A case-control study 2010 ·The Journal of Dermatology ·G. Aßmann, Claudia Pfoehler, Pierre Simon, Michael Pfreundschuh, Wolfgang Tilgen, Stefan Wieczorek	2
15	Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome 2009 ·Rheumatology International ·G. Aßmann, Annette D. Wagner, (unknown), Claudia Pfoehler, Michael Pfreundschuh, Wolfgang Tilgen, Klaus Roemer	27
16	Atherosclerosis in Apolipoprotein E-Deficient Mice is Decreased by the Suppression of Endogenous Sex Hormones 2001 ·Hormone and Metabolic Research ·(unknown), (unknown), (unknown), Claus Langer, Gerhard F. Weinbauer, H. M. Behre, Eberhard Nieschlag, G. Aßmann, Arnold von Eckardstein	27
17	Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis 1999 ·Nephrology Dialysis Transplantation ·Paul Cullen, (unknown), (unknown), (unknown), (unknown), Thomas Mehrens, G. Aßmann, R. M. Schaefer	57
18	Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men 1998 ·Blood Coagulation & Fibrinolysis ·R. Junker, J. J. Heinrich, H. Schulte, (unknown), (unknown), (unknown), (unknown), G. Aßmann	25
19	Genes and dyslipoproteinaemias 1990 ·European Heart Journal ·G. Aßmann	7
20	Lipid metabolism and atherosclerosis 1982 ·G. Aßmann	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact